دورية أكاديمية
Amivantamab, an Epidermal Growth Factor Receptor (EGFR) and Mesenchymal-epithelial Transition Factor (MET) Bispecific Antibody, Designed to Enable Multiple Mechanisms of Action and Broad Clinical Applications
| العنوان: | Amivantamab, an Epidermal Growth Factor Receptor (EGFR) and Mesenchymal-epithelial Transition Factor (MET) Bispecific Antibody, Designed to Enable Multiple Mechanisms of Action and Broad Clinical Applications |
|---|---|
| المؤلفون: | Cho, Byoung Chul, Simi, Allison, Sabari, Joshua, Vijayaraghavan, Smruthi, Moores, Sheri, Spira, Alexander |
| المصدر: | Clinical Lung Cancer ; volume 24, issue 2, page 89-97 ; ISSN 1525-7304 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2023 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.cllc.2022.11.004 |
| الإتاحة: | https://doi.org/10.1016/j.cllc.2022.11.004Test https://api.elsevier.com/content/article/PII:S152573042200256X?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S152573042200256X?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/ |
| رقم الانضمام: | edsbas.651F84E7 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.cllc.2022.11.004 |
|---|